Bids Are Invited For Acquisition Of Oncological Drugs

Acquisition Of Oncological Drugs. Acalabrutinib, Goserelin Acetate, Goserelin Acetate, Leuprorelin Acetate, Leuprorelin Acetate, Leuprorelin Acetate, Zoledronic Acid, Atezolizumab, Azacitidine, Bevacizumab, Bevacizumab, Bleomycin Sulfate, Bortezomib, Carboplatin, Carboplatin, Cemipilmab, Cetuximab, Cyclophosphamide, Cyclophosphamide, Cisplatin, Cisplatin, Cytarabine, Cytarabine, Doxorubicin Hydrochloride, Doxorubicin Hydrochloride, Dacarbazine, Daratumumab, Daratumumab, Daunorubicin, Denosumab, Dexrazoxane, Docetaxel, Docetaxel, Doxorubicin Hydrochloride, Durvalumab, Dur Valumab, Epirubicin Hydrochloride, Epirubicin Hydrochloride, Eribulin Mesylate, Etoposide, Filgrastim, Fludarabine Phosphate, Fluoruracil, Fluoruracil, Calcium Folinate, Calcium Folinate, Fosaprepitant Dimeglumine, Fulvestrant, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride, Idarubicin Hydrochloride, Idarrub Icine Hydrochloride, Ifosfamide, Ifosfamide, Ipilimumab, Irinotecan Hydrochloride, Melphalan, Mesna, Methotrexate, Methotrexate, Mitoxantrone Hydrochloride, Paclitaxel, Nivolumab, Nivolumab, Oxaliplatin, Oxaliplatin, Paclitaxel, Paclitaxel, Paclitaxel, Sodium Pamidronate, Panitumomab, Pegfilgrastim, Pembroliz Umab, Pemetrexed, Pertuzumab, Ramucirumab, Rituximab, Rituximab, Rituximab, Temozolomide, Topotecan Hydrochloride, Trastuzumab, Trastuzumab, Trastuzumab, Trastuzumab, Trastuzumab, Vinblastine, Vincristine, Vinorelbine, Vinorelbine